Diabetes obesity & metabolism, 1462-8902

Journal

Related Publications
  1. Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL

    Idzerda, N. M. A., Clegg, L. E., Hernandez, A. F., Bakris, G., Penland, R. C., Boulton, D. W., Bethel, M. A., Holman, R. R. & Heerspink, H. J. L., May-2020, In : Diabetes obesity & metabolism. 22, 5, p. 798-806 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. A placebo-controlled proof-of-concept study of alirocumab on postprandial lipids and vascular elasticity in insulin-treated patients with type 2 diabetes mellitus

    Burggraaf, B., Pouw, N. M. C., Fernandez Arroyo, S., van Vark-van der Zee, L. C., van de Geijn, G-J. M., Birnie, E., Huisbrink, J., van der Zwan, E. M., Mulder, M. T., Rensen, P. C. N., de Herder, W. W. & Cabezas, M. C., May-2020, In : Diabetes obesity & metabolism. 22, 5, p. 807-816 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from theLEADERrandomized trial

    LEADER Trial Investigators, Mosenzon, O., Bain, S. C., Heerspink, H. J. L., Idorn, T., Mann, J. F. E., Persson, F., Pratley, R. E., Rasmussen, S., Rossing, P., von Scholten, B. J. & Raz, I., 7-Aug-2020, In : Diabetes obesity & metabolism. 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program

    Ohkuma, T., Van Gaal, L., Shaw, W., Mahaffey, K. W., de Zeeuw, D., Matthews, D. R., Perkovic, V. & Neal, B., Apr-2020, In : Diabetes obesity & metabolism. 22, 4, p. 530-539 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (63) »

ID: 4952827